ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,338, issued on April 7, was assigned to King Faisal Specialist Hospital & Research Centre (Riyadh, Saudi Arabia).

"Cisplatin analogue with potent anti-cancer effects and synthesis thereof" was invented by Abdelilah Aboussekhra (Riyadh, Saudi Arabia), Ibrahim Al-Jammaz (Riyadh, Saudi Arabia), Basem Al-Otaibi (Riyadh, Saudi Arabia) and Noura N. Alraouji (Riyadh, Saudi Arabia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound comprising a cisplatin component and a eugenol component. The present invention further relates to a synthesis method of said compound, pharmaceutical compositions comprising the compound an...